164 related articles for article (PubMed ID: 6813497)
1. Pharmacokinetics of auranofin in animals.
Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
[TBL] [Abstract][Full Text] [Related]
2. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
[TBL] [Abstract][Full Text] [Related]
3. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
[TBL] [Abstract][Full Text] [Related]
4. Comparative pharmacokinetics of parenteral and oral gold compounds.
Gottlieb NL
J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1980; 7(6):820-4. PubMed ID: 6782245
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
Furst DE; Dromgoole SH
Clin Rheumatol; 1984 Mar; 3 Suppl 1():17-24. PubMed ID: 6432409
[TBL] [Abstract][Full Text] [Related]
7. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
8. Gold excretion and retention during auranofin treatment: a preliminary report.
Gottlieb NL
J Rheumatol Suppl; 1979; 5():61-7. PubMed ID: 385875
[TBL] [Abstract][Full Text] [Related]
9. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
[TBL] [Abstract][Full Text] [Related]
10. Distribution of gold in blood following administration of auranofin (SK&F D-39162).
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol Suppl; 1979; 5():56-60. PubMed ID: 114638
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
12. Triethylphosphine gold: cellular uptake and disposition after single and repeated oral doses in rats.
Sharma RP; Smillie J; Laverty R
J Pharm Pharmacol; 1984 Jul; 36(7):441-5. PubMed ID: 6146687
[TBL] [Abstract][Full Text] [Related]
13. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
Blocka K
Am J Med; 1983 Dec; 75(6A):114-22. PubMed ID: 6419592
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action of auranofin: effects on humoral immune response.
Walz DT; Dimartino MJ; Griswold DE
J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
[TBL] [Abstract][Full Text] [Related]
15. Auranofin in rheumatoid arthritis.
Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
[No Abstract] [Full Text] [Related]
16. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological profile of auranofin, an orally active gold compound.
Walz DT; DiMartino MJ; Griswold DE
Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the kinetics of parenteral and oral gold.
Gottlieb NL
Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
[TBL] [Abstract][Full Text] [Related]
19. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
Giannini EH; Person DA; Brewer EJ; Parks DB
J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
[TBL] [Abstract][Full Text] [Related]
20. Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388.
Simon TM; Kunishima DH; Vibert GJ; Lorber A
Cancer Res; 1981 Jan; 41(1):94-7. PubMed ID: 6778607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
